Mechanisms of Bacterial Resistance to Microbicides

Russell, Hugo & Ayliffe's: Principles and Practice of Disinfection, Preservation and Sterilization

Volumn , Issue , 2012, Pages 108-120

  Maillard, Jean Yves ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cross resistance; Degradation; Efflux; Metabolism; Permeability

Indexed keywords

EID: 84887130669     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118425831.ch6a     Document Type: Chapter

References (212)

1. SCENIHR, Scientific Committee on Emerging and Newly Identified Health Risks (2009) The antibiotic resistance effect of biocides, adopted by the SCENIHR on January 19, 2009.
2. Maillard, J.-Y. and Denyer, S.P. (2009) Emerging bacterial resistance following biocide exposure: should we be concerned? Chemica Oggi, 27, 26-28.
3. Denyer, S.P. and Maillard, J.-Y. (2002) Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. Journal of Applied Microbiology,, 92(Suppl.), 35-45.
4. Lambert, P.A. (2002) Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. Journal of Applied Microbiology, 92(Suppl.), 46-55.
5. Maillard, J.-Y. (2002) Bacterial target sites for biocide action. Journal of Applied Microbiology, 92(Suppl.), 16-27.
6. Maillard, J.-Y. (2007) Bacterial resistance to biocides in the healthcare environment: shall we be concerned? Journal of Hospital Infection, 65(Suppl. 2), 60-72.
7. Gilbert, P. and Moore, L.E. (2005) Cationic antiseptics: diversity of action under a common epithet. Journal of Applied Microbiology, 99, 703-715.
8. Maillard, J.-Y. (2005) Biocides: health care application. Pharmaceutical Journal, 275, 639-642.
9. Tattawasart, U. et al. (2000) Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri. Journal of Antimicrobial Chemotherapy, 45, 145-152.
10. Tattawasart, U. et al. (2000) Membrane changes in Pseudomonas stutzeri strains resistant to chlorhexidine diacetate and cetylpyridinium chloride. International Journal of Antimicrobial Agents, 16, 233-238.
11. Braoudaki, M. and Hilton, A.C. (2005) Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. International Journal of Antimicrobial Agents, 25, 31-37.
12. Maillard, J.-Y. (2005) Usage of antimicrobial biocides and products in the healthcare environment: efficacy, policies, management and perceived problems. Therapeutics and Clinical Risk Management, 1, 340-370.
13. Bailey, A.M. et al. (2009) Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. Journal of Antimicrobial Chemotherapy, 64, 973-985.
14. Daniel, C. and Ramos, J.L. (2009) Adaptive drug resistance mediated by root-nodulation-cell division efflux pumps. Clinical Microbiology and Infection, 15, 32-36.
15. Maseda, H. et al. (2009) Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens. Antimicrobial Agents and Chemotherapy, 53, 5230-5235.
16. Duarte, R.S. et al. (2009) Epidemic of postsurgical infections caused by Mycobacterium massiliense. Journal of Clinical Microbiology, 47, 2149-2155.
17. Adair, F.W. et al. (1971) Resistance of Pseudomonas to quaternary ammonium compounds. Applied Microbiology, 21, 1058-1063.
18. Russell, A.D. (2002) Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. Journal of Applied Microbiology, 92(Suppl.), 121-135.
19. Chapman, J.S. (2003) Disinfectant resistance mechanisms, cross-resistance, and co-resistance. International Biodeterioration and Biodegradation, 51, 271-276.
20. Sanford, J.P. (1970) Disinfectants that don't. Annals of Internal Medicine, 72, 282-283.
21. Prince, J. and Ayliffe, G.A.J. (1972) In-use testing of disinfectants in hospitals. Journal of Clinical Pathology, 25, 586-589.
22. Centers for Disease Control (1974) Disinfectant or Infectant: The Label Doesn't Always Say, National Nosocomial Infections Study, Fourth Quarter, 1973, p. 18
23. Griffiths, P.A. et al. (1997) Glutaraldehyde-resistant Mycobacterium chelonae from endoscope washer disinfectors. Journal of Applied Microbiology, 82, 519-526.
24. Martin, D.J.H. et al. (2008) Resistance and cross-resistance to oxidising agents of bacterial isolates from endoscope washer disinfectors. Journal of Hospital Infection, 69, 377-383.
25. Cookson, B. (2005) Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment. Journal of Applied Microbiology, 99, 989-996.
26. Chapman, J.S. (1998) Characterizing bacterial resistance to preservatives and disinfectants. International Biodeterioration and Biodegradation, 41, 241-245.
27. Chapman, J.S. et al. (1998) Preservative tolerance and resistance. International Journal of Cosmetics, 20, 31-39.
28. Hammond, S.A. et al. (1987) Comparative susceptibility of hospital isolates of gram-negative bacteria to antiseptics and disinfectants. Journal of Hospital Infection, 9, 255-264.
29. Russell, A.D. (2003) Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical environmental situations. Lancet Infectious Diseases, 3, 794-803.
30. Cloete, T.E. (2003) Resistance mechanisms of bacteria to antimicrobial compounds. International Biodeterioration and Biodegradation, 51, 277-282.
31. Stickler, D.J. (1974) Chlorhexidine resistance in Proteus mirabilis. Journal of Clinical Pathology, 27, 284-287.
32. Gillespie, M.T. et al. (1986) Plasmid-encoded resistance to acriflavine and quaternary ammonium compounds in methicillin-resistant Staphylococcus aureus. FEMS Microbiology Letters, 34, 47-51.
33. Randall, L.P. et al. (2001) Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. Journal of Medical Microbiology, 50, 919-924.
34. Romao, C.M.C.P.A. et al. (2005) Susceptibility of clinical isolates of multiresist-ant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing. Memorias do Instituto Oswaldo Cruz, 100, 541-548.
35. Sasatsu, M. et al. (1993) Triclosan-resistant Staphylococcus aureus. Lancet, 341, 756.
36. Heath, R.J. et al. (1998) Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. Journal of Biological Chemistry, 273, 30316-30320.
37. Bamber, A.I. and Neal, T.J. (1999) An assessment of triclosan susceptibility in methicillin resistant and methicillin sensitive Staphylococcus aureus. Journal of Hospital Infection, 41, 107-109.
38. Randall, L.P. et al. (2004) Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. Journal of Antimicrobial Chemotherapy, 54, 621-627.
39. O'Rrourke, E.O. et al. (2003) Contaminated iodophor in the operating room. American Journal of Infection Control, 31, 255-256.
40. Motgatla, R.M. et al. (1998) Isolation of Salmonella resistant to hypochlorous acid from a poultry abattoir. Letters in Applied Microbiology, 27, 379-382.
41. Motgatla, R.M. et al. (2002) Mechanisms contributing to hypochlorous acid resistance of a Salmonella isolate from a poultry-processing plant. Journal of Applied Microbiology, 92, 566-573.
42. Van Klingeren, B. and Pullen, W. (1993) Glutaraldehyde resistant mycobacteria from endoscope washers. Journal of Hospital Infection, 25, 147-149.
43. Manzoor, S.E. et al. (1999) Reduced glutaraldehyde susceptibility in Mycobacterium chelonae associated with altered cell wall polysaccharides. Journal of Antimicrobial Chemotherapy, 43, 759-765.
44. Fraud, S. et al. (2001) Comparison of the mycobactericidal activity of ortho-phthalaldehyde, glutaraldehyde and other dialdehydes by a quantitative suspension test. Journal of Hospital Infection, 48, 214-221.
45. Walsh, S.E. et al. (2001) Possible mechanisms for the relative efficacies of ortho-phthalaldehyde and glutaraldehyde against glutaraldehyde-resistant Mycobacterium chelonae. Journal of Applied Microbiology, 91, 80-92.
46. Nomura, K. et al. (2004) Antibiotic susceptibility of glutaraldehyde tolerant Mycobacetrium chelonae from bronchoscope washing machine. American Journal of Infection Control, 32, 185-188.
47. Greenberg, J.T. and Demple, B. (1989) A global response induced in Escherichia coli by redox cycling agents overlaps with that induced by peroxide stress. Journal of Bacteriology, 171, 3933-3939.
48. Greenberg, J.T. et al. (1990) Positive control of a global antioxidant defence regulon activated by superoxide-generating agents in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 87, 6181-6185.
49. Dukan, S. and Touati, D. (1996) Hypochlorous acid stress in Escherichia coli: resistance, DNA damage, and comparison with hydrogen peroxide stress. Journal of Bacteriology, 178, 6145-6150.
50. Flores, M. et al. (1997) Deterioration of raw materials and cosmetic products by preservative resistant micro-organisms. International Biodeterioration and Biodegradation, 40, 157-160.
51. Hutchinson, J. et al. (2004) Burkholderia cepacia infections associated with intrinsically contaminated ultrasound gel: the role of microbial degradation of parabens. Infection Control and Hospital Epidemiology, 25, 291-296.
52. Tattawasart, U. et al. (1999) Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. Journal of Hospital Infection, 42, 219-229.
53. Thomas, L. et al. (2000) Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of "residual" concentration. Journal of Hospital Infection, 46, 297-303.
54. Winder, C.L. et al. (2000) Outer membrane protein shifts in biocide-resistant Pseudomonas aeruginosa PAO1. Journal of Applied Microbiology, 89, 289-295.
55. McMurry, L.M. et al. (1998) Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiology Letters, 166, 305-309.
56. McMurry, L.M. et al. (1999) Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy, 43, 711-713.
57. Walsh, S.E. et al. (2003) Development of bacterial resistance to several biocides and effects on antibiotic susceptibility. Journal of Hospital Infection, 55, 98-107.
58. Cottell, A. et al. (2009) Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. Journal of Hospital Infection, 72, 71-76.
59. Thomas, L. et al. (2005) Antimicrobial activity of chlorhexidine diacetate and benzalkonium chloride against Pseudomonas aeruginosa and its response to biocide residues. Journal of Applied Microbiology, 98, 533-543.
60. Wisplinghoff, H. et al. (2007) Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. Journal of Hospital Infection, 66, 174-181.
61. Monteros, L.E.E.D.L. et al. (2008) Outbreak of infection by extended-spectrum beta-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital. Journal of Chemotherapy, 20, 586-592.
62. Lear, J.C. et al. (2002) Chloroxylenol-and triclosan-tolerant bacteria from industrial sources. Journal of Industrial Microbiology and Biotechnology, 29, 238-242.
63. Moyer, C.A. et al. (1965) Treatment of large burns with 0.5% silver nitrate solution. Archives of Surgery, 90, 812-867.
64. Cason, J.S. et al. (1966) Antiseptic and septic prophylaxis for burns: use of silver nitrate and of isolators. British Medical Journal, 2, 1288-1294.
65. Bridges, K. and Lowbury, E.J.L. (1977) Drug-resistance in relation to use of sliver sulfadiazine cream in a burns unit. Journal of Clinical Pathology, 30, 160-164.
66. Klasen, H.J. (2000) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns, 26, 131-138.
67. Reiss, I. et al. (2000) Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet, 356, 310.
68. Weber, D.J. et al. (2007) Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrobial Agents and Chemotherapy, 51, 4217-4224.
69. McMurry, L.M. et al. (1998) Triclosan targets lipid synthesis. Nature, 394, 531-532.
70. Levy, C.W. et al. (1999) Molecular basis of triclosan activity. Nature, 398, 384-385.
71. Roujeinikova, A. et al. (1999) Crystallographic analysis of triclosan bound to enoyl reductase. Journal of Molecular Biology, 294, 527-535.
72. Stewart, M.J. et al. (1999) Structural basis and mechanisms of enoyl reductase inhibition by triclosan. Journal of Molecular Biology, 290, 859-865.
73. Parikh, S.L. et al. (2000) Inhibition of InhA, enoyl reductase from Mycobacterium tuberculosis by triclosan and isoniazid. Biochemistry, 39, 7645-7650.
74. Webber, M.A. et al. (2008) Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. Journal of Antimicrobial Chemotherapy, 62, 92-97.
75. McDonnell, G. and Russell, A.D. (1999) Antiseptics and disinfectants: activity, action and resistance. Clinical Microbiology Reviews, 12, 147-179.
76. Mc Cay, P.H. et al. (2010) Effect of subinhibitory concentrations of benzalko-nium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology, 156, 30-38.
77. Cheeseman, K.E. et al. (2009) Evaluation of the bactericidal efficacy of three different alcohol hand rubs against 57 clinical isolates of Staphylococcus aureus. Journal of Hospital Infection, 72, 319-325.
78. Williams, G.J. et al. (2009) The use of sodium dichloroisocyanurate, NaDCC, in Welsh ITUs. Journal of Hospital Infection, 72, 279-281.
79. Poole, K. (2002) Mechanisms of bacterial biocide and antibiotic resistance. Journal of Applied Microbiology, 92(Suppl.), 55-64.
80. Piddock, L.J.V. (2006) Multidrug resistance efflux pumps-not just for resistance. Nature Reviews Microbiology, 4, 629-636.
81. Poole, K. (2007) Efflux pumps as antimicrobial resistance mechanisms. Annals of Medicine, 39, 162-176.
82. Maillard, J.-Y. (2010) Incidence of sporicide resistance and risk to the population. Journal of Hospital Infection, 77, 204-209.
83. Lyon, B.R. and Skurray, R.A. (1987) Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiology Reviews, 51, 88-134.
84. Silver, S. et al. (1989) Bacterial ATPases-primary pumps for exploring toxic cations and anions. Trends in Biochemical Sciences, 14, 76-80.
85. White, D.G. and McDermott, P.F. (2001) Biocides, drug resistance and microbial evolution. Current Opinion in Microbiology, 4, 313-317.
86. Kücken, D. et al. (2000) Association of qacE and qacEΔI with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria. FEMS Microbiology Letters, 183, 95-98.
87. Bjorland, J. et al. (2001) Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. Journal of Clinical Microbiology, 39, 3999-4004.
88. Pearce, H. et al. (1999) Effect of biocides commonly used in the hospital environment on the transfer of antibiotic-resistance genes in Staphylococcus aureus. Journal of Hospital Infection, 43, 101-108.
89. Karatzas, K.A.G. et al. (2008) Phenotypic and proteomic characterisation of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimu-rium selected following exposure to disinfectants. Applied and Environmental Microbiology, 74, 1508-1516.
90. Chen, Y. et al. (2009) Triclosan resistance in clinical isolates of Acinetobacter baumannii. Journal of Medical Microbiology, 58, 1086-1091.
91. Russell, A.D. (2002) Antibiotic and biocide resistance in bacteria: comments and conclusion. Journal of Applied Microbiology, 92(Suppl.), 171-173.
92. Champlin, F.R. et al. (2005) Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 26, 159-164.
93. Russell, A.D. et al. (1997) Microbial susceptibility and resistance to biocides: an understanding. ASM News, 63, 481-487.
94. Russell, A.D. (1990) Bacterial spores and chemical sporicidal agents. Clinical Microbiology Reviews, 3, 99-119.
95. Fraud, S. et al. (2003) Effects of ortho-phthalaldehyde, glutaraldehyde and chlorhexidine diacetate on Mycobacterium chelonae and M. abscessus strains with modified permeability. Journal of Antimicrobial Chemotherapy, 51, 575-584.
96. Munton, T.J. and Russell, A.D. (1970) Effect of glutaraldehyde on protoplasts of Bacillus megaterium. Journal of General Microbiology, 63, 367-370.
97. Ayres, H.M. et al. (1998) Effect of permeabilizing agents on antibacterial activity against a simple Pseudomonas aeruginosa biofilm. Letters in Applied Microbiology, 27, 79-82.
98. Gandhi, P.A. et al. (1993) Adaptation and growth of Serratia marcescens in contact lens disinfectant solution containing chlorhexidine gluconate. Applied and Environmental Microbiology, 59, 183-188.
99. Brözel, V.S. and Cloete, T.E. (1994) Resistance of Pseudomonas aeruginosa to isothiazolone. Journal of Applied Bacteriology, 76, 576-582.
100. Jones, M.W. et al. (1989) Resistance of Pseudomonas aeruginosa to amphoteric and quaternary ammonium biocides. Microbios, 58, 49-61.
101. Méchin, L. et al. (1999) Adaptation of Pseudomonas aeruginosa ATCC 15442 to didecyldimethylammonium bromide induces changes in membrane fatty acid composition and in resistance of cells. Journal of Applied Microbiology, 86, 859-866.
102. Guérin-Méchin, L. et al. (1999) Specific variations of fatty acid composition of Pseudomonas aeruginosa ATCC 15442 induced by quaternary ammonium compounds and relation with resistance to bactericidal activity. Journal of Applied Microbiology, 87, 735-742.
103. Guérin-Méchin, L. et al. (2000) Quaternary ammonium compounds stresses induce specific variations in fatty acid composition of Pseudomonas aeruginosa. International Journal of Food Microbiology, 55, 157-159.
104. Boeris, P.S. et al. (2007) Modification of phospholipid composition in Pseudomonas putida A ATCC 12633 induced by contact with tetradecyltrimethyl-ammonium. Journal of Applied Microbiology, 103, 1048-1054.
105. McNeil, M.R. and Brennan, P.J. (1991) Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Research in Microbiology, 142, 451-463.
106. Broadley, S.J. et al. (1995) Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol. Journal of Medical Microbiology, 43, 458-460.
107. Russell, A.D. (1996) Activity of biocides against mycobacteria. Journal of Applied Bacteriology, 81, 87-101.
108. Bruinsma, G.M. et al. (2006) Resistance to a polyquaternium-1 lens care solution and isoelectric points of Pseudomonas aeruginosa strains. Journal of Antimicrobial Chemotherapy, 57, 764-766.
109. Brown, M.H. et al. (1999) The multidrug efflux protein NorM is a prototype of a new family of transporters. Molecular Microbiology, 31, 393-395.
110. Borges-Walmsley, M.I. and Walmsley, A.R. (2001) The structure and function of drug pumps. Trends in Microbiology, 9, 71-79.
111. Poole, K. (2001) Multidrug resistance in Gram-negative bacteria. Current Opinion in Microbiology, 4, 500-508.
112. Poole, K. (2002) Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Current Pharmaceutical Biotechnology, 3, 77-98.
113. McKeegan, K.S. et al. (2003) The structure and function of drug pumps: an update. Trends in Microbiology, 11, 21-29.
114. Tennent, J.M. et al. (1989) Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. Journal of General Microbiology, 135, 1-10.
115. Littlejohn, T.G. et al. (1992) Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiology Letters, 95, 259-266.
116. Leelaporn, A. et al. (1994) Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. Journal of Medical Microbiology, 40, 214-220.
117. Heir, E. et al. (1998) The Staphylococcus qacH gene product: a new member of the SMR family encoding multidrug resistance. FEMS Microbiology Letters, 163, 49-56.
118. Heir, E. et al. (1999) The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. Journal of Applied Microbiology, 86, 378-388.
119. Rouche, D.A. et al. (2051) 1990) Efflux-mediated antiseptic gene qacA in Staphylococcus aureus: common ancestry with tetracycline and sugar transport proteins. Molecular Microbiology, 4, 2062.
120. Chuanchuen, R. et al. (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nxfB mutants overexpressing MexCD-OprJ. Antimicrobial Agents and Chemotherapy, 45, 428-432.
121. Chuanchuen, R. et al. (2002) The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for effect of triclosan. Journal of Bacteriology, 184, 5036-5044.
122. Randall, L.P. et al. (2007) Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence. Journal of Antimicrobial Chemotherapy, 60, 1273-1280.
123. Webber, M.A. et al. (2008) Triclosan resistance in Salmonella enterica serovar Typhimurium. Journal of Antimicrobial Chemotherapy, 62, 83-91.
124. Mima, T. et al. (2007) Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins. Journal of Bacteriology, 189, 7600-7609.
125. Schweizer, H.P. (1998) Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrobial Agents and Chemotherapy, 42, 394-398.
126. Chuanchuen, R. et al. (2003) High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. American Journal of Infection Control, 31, 124-127.
127. Levy, S.B. (2002) Active efflux, a common mechanism for biocide and antibiotic resistance. Journal of Applied Microbiology, 92(Suppl.), 65-71.
128. Kummerle, N. et al. (1996) Plasmid-mediated formaldehyde resistance in Escherichia coli: characterization of resistance gene. Antimicrobial Agents and Chemotherapy, 40, 2276-2279.
129. Demple, B. (1996) Redox signaling and gene control in the Escherichia coli soxRS oxidative stress regulon-a review. Gene, 179, 53-57.
130. Valkova, N. et al. (2001) Hydrolysis of 4-hydroxybenzoic acid esters (parabens) and their aerobic transformation into phenol by the resistant Enterobacter cloacae strain EM. Applied and Environmental Microbiology, 67, 2404-2409.
131. Codling, C.E. et al. (2004) Identification of genes involved in the resistance Serratia marcescens to polyquaternium-1. Journal of Antimicrobial Chemotherapy, 54, 370-375.
132. Stickler, D.J. (2004) Intrinsic resistance of Gram-negative bacteria, in Principles and Practice of Disinfection, Preservation and Sterilization, 4th edn (eds A.P. Fraise et al.), Blackwell Scientific Publications, Oxford, pp. 154-169
133. Sundheim, G. et al. (1998) Bacterial resistance to disinfectants containing quaternary ammonium compounds. International Biodeterioration and Biodegradation, 41, 235-239.
134. Morita, Y. et al. (2003) Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. Journal of Antimicrobial Chemotherapy, 51, 991-994.
135. Moken, M.C. et al. (1997) Selection of multiple-antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents and Chemotherapy, 41, 2770-2772.
136. Nishino, K. and Yamagushi, A. (2001) Analysis of a complete library of putative drug transporter genes in Escherichia coli. Journal of Bacteriology, 183, 5803-5812.
137. Lomovskaya, O. and Lewis, K. (1992) emr, an Escherichia coli locus for multidrug resistance. Proceedings of the National Academy of Sciences of the United States of America, 89, 8938-8942.
138. Davin-Regli, A. et al. (2008) Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Current Drug Targets, 9, 750-759.
139. Rajamohan, G. et al. (2010) Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. Journal of Antimicrobial Chemotherapy, 65, 228-232.
140. Buckley, A. et al. (2006) The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cellular Microbiology, 8, 847-856.
141. Sánchez, P. et al. (2005) The biocide triclosan selects Stenotrophomonas mal-tophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrobial Agents and Chemotherapy, 49, 781-782.
142. Pumbwe, L. et al. (2005) Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiply antibiotic-resistant Campylobacter spp. Journal of Antimicrobial Chemotherapy, 54, 341-347.
143. Tkachenko, O. et al. (2007) A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes. Research in Microbiology, 158, 651-658.
144. Heath, R. et al. (1999) Mechanism of triclosan inhibition of bacterial fatty acid biosynthesis. Journal of Biological Chemistry, 274, 11110-11114.
145. Zhu, L. et al. (2010) Triclosan resistance of Pseudomonas aeruginosa PA01 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase. Antimicrobial Agents and Chemotherapy, 54, 689-698.
146. Heath, R.J. et al. (2000) Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachloroph-ene. Journal of Biological Biochemistry, 275, 4654-4659.
147. Slater-Radosti, C. et al. (2001) Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 48, 1-6.
148. Massengo-Tiassé, R.P. and Cronan, J.E. (2008) Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase. Journal of Biological Chemistry, 283, 1308-1316.
149. Brown, M.R.W. and William, P. (1985) Influence of substrate limitation and growth-phase on sensitivity to antimicrobial agents. Journal of Antimicrobial Chemotherapy, 15, 7-14.
150. Wright, N.E. and Gilbert, P. (1987) Influence of specific growth rate and nutrient limitation upon the sensitivity of Escherichia coli towards chlorhexidine diacetate. Journal of Applied Bacteriology, 62, 309-314.
151. Gomez Escalada, M. et al. (2005) Triclosan inhibition of fatty acid synthesis and its effect on growth of E. coli and Ps. aeruginosa. Journal of Antimicrobial Chemotherapy, 55, 879-882.
152. Ma, D. et al. (1994) Efflux pumps and drug resistance in Gram-negative bacteria. Trends in Microbiology, 2, 489-493.
153. 3. Letters in Applied Microbiology, 29, 323-326.
154. Allen, M.J. et al. (2006) The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology, 152, 989-1000.
155. Jang, H.-J. et al. (2008) Microarray analysis of toxicogenomic effects of tri-closan on Staphylococcus aureus. Applied Microbiology and Biotechnology, 78, 695-707.
156. Abdel Malek, S.M.A. et al. (2002) Antimicrobial susceptibility changes and T-OMP shifts in pythione-passaged planktonic cultures of Pseudomonas aeruginosa PAO1. Journal of Applied Microbiology, 92, 729-736.
157. Kastbjerg, V.G. et al. (2010) Influence of sublethal concentrations of common disinfectants on expression of virulence genes in Listeria monocytogenes. Applied and Environmental Microbiology, 76, 303-309.
158. Gilbert, P. et al. (2003) Formation of microbial biofilm in hygienic situations: a problem of control. International Biodeterioration and Biodegradation, 51, 245-248.
159. Bisset, L. et al. (2006) A prospective study of the efficacy of routine decontamination for gastrointestinal endoscopes and the risk factors for failure. American Journal of Infection Control, 34, 274-280.
160. Smith, K. and Hunter, I.S. (2008) Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. Journal of Medical Microbiology, 57, 966-973.
161. Brown, M.R.W. and Gilbert, P. (1993) Sensitivity of biofilms to antimicrobial agents. Journal of Applied Bacteriology, 74(Suppl.), 87-97.
162. Ashby, M.J. et al. (1994) Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. Journal of Antimicrobial Chemotherapy, 33, 443-452.
163. Das, J.R. et al. (1998) Changes in the biocide susceptibility of Staphylococcus epidermidis and Escherichia coli cells associated with rapid attachment to plastic surfaces. Journal of Applied Microbiology, 84, 852-858.
164. Pan, Y. et al. (2006) Resistance of Listeria monocytogenes biofilms to sanitizing agents in a simulated food processing environment. Applied and Environmental Microbiology, 72, 7711-7717.
165. Tart, A.H. and Wozniak, D.J. (2008) Shifting paradigms in Pseudomonas aeruginosa biofilm research. Current Topics in Microbiology and Immunology, 322, 193-206.
166. Sondossi, M. et al. (1985) Observations of resistance and cross-resistance to formaldehyde and a formaldehyde condensate biocide in Pseudomonas aeruginosa. International Biodeterioration, 21, 105-106.
167. Huang, C.T. et al. (1995) Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Applied and Environmental Microbiology, 61, 2252-2256.
168. Maira-Litrán, T. et al. (2000) An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. Journal of Antimicrobial Chemotherapy, 45, 789-795.
169. Lai, S. et al. (2009) Swarming motility: a multicellular behaviour conferring antimicrobial resistance. Environmental Microbiology, 11, 126-136.
170. Moore, L.E. et al. (2008) In vitro study of the effect of cationic biocides on bacterial population dynamics and susceptibility. Applied and Environmental Microbiology, 74, 4825-4834.
171. McBain, A.J. et al. (2004) Effects of quaternary-ammonium based formulations on bacterial community dynamics and antimicrobial susceptibility. Applied and Environmental Microbiology, 70, 3449-3456.
172. Kümmerer, K. et al. (2002) Use of chemotaxonomy to study the influence of benzalkonium chloride on bacterial populations in biodegradation testing. Acta Hydrochima et Hydrobiologica, 30, 171-178.
173. McBain, A.J. et al. (2003) Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility. Applied and Environmental Microbiology, 69, 5433-5442.
174. Jones, G.Ll, et al. (2006) Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. Journal of Antimicrobial Chemotherapy, 57, 266-272.
175. Stickler, D.J. and Jones, G.L. (2008) Reduced Susceptibility of Proteus mirabilis to triclosan. Antimicrobial Agents and Chemotherapy, 52, 991-994.
176. Davison, J. (1999) Genetic exchange between bacteria in the environment. Plasmid, 42, 73-91.
177. Roberts, A.P. and Mullany, P. (2009) A modular master on the move: the Tn916 family of mobile genetic elements. Trends in Microbiology, 17, 251-258.
178. Schlüter, A. et al. (2007) Genomics of IncP-1 antibiotic resistance plasmids isolated from wastewater treatment plants provides evidence for a widely accessible drug resistance gene pool. FEMS Microbiology Reviews, 31, 449-477.
179. Sidhu, M.S. et al. (2002) Frequency of disinfectant resistance genes and genetic linkage with beta-lactamase transposon Tn552 among clinical staphylococci. Antimicrobial Agents and Chemotherapy, 46, 2797-2803.
180. Paulsen, I.T. et al. (1998) Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. Journal of Bacteriology, 180, 3477-3479.
181. Sidhu, M.S. et al. (2001) Genetic linkage between resistance to quaternary ammonium compounds and beta-lactam antibiotics in food-related Staphylococcus spp. Microbial Drug Resistance, 7, 363-371.
182. Noguchi, N. et al. (2005) Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. Journal of Medical Microbiology, 54, 557-565.
183. Hansen, L.H. et al. (2005) The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs. Microbial Drug Resistance, 11, 378-382.
184. Hansen, L.H. et al. (2007) Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. Journal of Antimicrobial Chemotherapy, 60, 145-147.
185. Laraki, N. et al. (1999) Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrobial Agents and Chemotherapy, 43, 890-901.
186. Quinn, T. et al. (2006) Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Current Drug Targets, 7, 849-860.
187. Hawkey, P.M. and Jones, A.M. (2009) The changing epidemiology of resistance. Journal of Antimicrobial Chemotherapy, 64(Suppl. 1), 3-10.
188. Juhas, M. et al. (2009) Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiology Reviews, 33, 376-393.
189. Birošová, L. and Mikulášová, M. (2009) Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium. Journal of Medical Microbiology, 58, 436-441.
190. Davies, D.G. et al. (1998) The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science, 280, 295-298.
191. Shih, P.C. and Huang, C.T. (2002) Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. Journal of Antimicrobial Chemotherapy, 49, 309-314.
192. MacLehose, H.G. et al. (2004) Biofilms, homoserine lactones and biocide susceptibility. Journal of Antimicrobial. Chemotherapy, 53, 180-184.
193. Davies, A.J. and Maillard, J.-Y. (2001) Bacterial adaptation to biocides: the possible role of "alarmones". Journal of Hospital Infection, 49, 300-301.
194. Cerf, O. et al. (2010) Tests for determining in-use concentrations of antibiotics and disinfectants are based on entirely different concepts: "resistance" has different meanings. International Journal of Food Microbiology, 136, 247-254.
195. Russell, A.D. and McDonnell, G. (2000) Concentration: a major factor in studying biocidal action. Journal of Hospital Infection, 44, 1-3.
196. Langsrud, S. et al. (2003) Bacterial disinfectant resistance-a challenge for the food industry. International Biodeterioration and Biodegradation, 51, 283-290.
197. Lear, J.C. et al. (2006) Chloroxylenol-and triclosan-tolerant bacteria from industrial sources-susceptibility to antibiotics and other biocides. International Biodeterioration and Biodegradation, 57, 51-56.
198. Gomez Escalada, M. et al. (2005) Triclosan-bacteria interactions: single or multiple target sites? Letters in Applied Microbiology, 41, 476-481.
199. Braoudaki, M. and Hilton, A.C. (2004) Adaptive resistance in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. Journal of Clinical Microbiology, 42, 73-78.
200. Braoudaki, M. and Hilton, A.C. (2004) Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O5 compared to E. coli O157. FEMS Microbiology Letters, 235, 305-309.
201. Gilbert, P. and McBain, A.J. (2003) Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clinical Microbiology Review, 16, 189-208.
202. Russell, A.D. (2004) Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. Journal of Hospital Infection, 57, 97-104.
203. Aiello, A.E. et al. (2005) Antibacterial cleaning products and drug resistance. Emerging Infectious Diseases, 11, 1565-1570.
204. Aiello, A.E. et al. (2007) Consumer antibacterial soaps: effective or just risky? Clinical Infectious Diseases, 45(Suppl. 2), 137-147.
205. Alonso-Hernando, A. et al. (2009) Comparison of antibiotic resistance patterns in Listeria monocytogenes and Salmonella enterica strains pre-exposed and exposed to poultry decontaminants. Food Control, 20, 1108-1111.
206. Weber, D.J. and Rutala, W.A. (2006) Use of germicides in the home and the health care setting: is there a relationship between germicide use and antibiotic resistance? Infection Control and Hospital Epidemiology, 27, 1107-1119.
207. Pumbwe, L. et al. (2007) Induction of multiple antibiotic resistance in Bacter-oides fragilis by benzene and benzene-derived active compounds of commonly used analgesics, antiseptics and cleaning agents. Journal of Antimicrobial Chemotherapy, 60, 1288-1297.
208. Lara, H.H. et al. (2010) Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World Journal of Microbiology and Biotechnology, 26, 615-621.
209. Walsh, C. and Fanning, S. (2008) Antimicrobial resistance in foodborne pathogens-a cause for concern? Current Drug Targets, 9, 808-815.
210. Fraise, A.P. (2004) Biocide abuse and antimicrobial resistance-a cause for concern. Journal of Antimicrobial Chemotherapy, 49, 11-12.
211. Carson, R.T. et al. (2008) Use of antibacterial consumer products containing quaternary ammonium compounds and drug resistance in the community. Journal of Antimicrobial Chemotherapy, 62, 1160-1162.
212. Cole, E.C. et al. (2003) Investigation of antibiotic and antibacterial agent crossresistance in target bacteria from homes of antibacterial product users and non users. Journal of Applied Microbiology, 95, 664-679.